SCHEDULE: Mason Capital Discloses 5.8% Stake in Veradigm

Mason Capital Management and its principals have disclosed a 5.8% beneficial ownership stake in Veradigm Inc., totaling 6,283,161 shares.

Summary

• Mason Capital Management LLC, Kenneth M. Garschina, and Michael E. Martino have jointly reported beneficial ownership of 6,283,161 shares of Veradigm Inc. Common Stock.
• This represents 5.8% of Veradigm Inc.'s outstanding Common Stock.
• The percentage is calculated based on 108,900,000 shares outstanding as of September 29, 2025, as reported in Veradigm Inc.'s Current Report on Form 8-K filed on September 30, 2025.
• The reporting persons share both voting and dispositive power over all 6,283,161 shares.
• The acquisition was not for the purpose of changing or influencing control of Veradigm Inc., other than activities solely in connection with a nomination under Rule 14a-11.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a moderately positive development, as a significant stake by an institutional investor often signals confidence in the company's valuation or future prospects, without indicating an activist intent.

Positives

• A significant investment firm, Mason Capital Management, has taken a notable 5.8% stake in Veradigm Inc., potentially signaling confidence in the company's future valuation or strategic direction.

Negatives

• The filing itself does not contain any negative information regarding Veradigm Inc.'s operations or financial performance.

Risks

• The filing includes a standard certification that the securities were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer, other than activities solely in connection with a nomination under Rule 14a-11.

Future Outlook

The filing does not provide any forward-looking statements or guidance from Veradigm Inc. or the reporting persons regarding the company's future performance.

Industry Context

StockSavvy.ai notes that a significant stake by an investment manager like Mason Capital Management in a healthcare technology company such as Veradigm Inc. can attract market attention, potentially indicating perceived value or strategic interest in the sector.

Stakeholder Impact

• Shareholders: The disclosure of a new significant institutional investor could positively influence market perception and potentially the stock price.
• Company Management: Awareness of a new 5.8% shareholder may influence strategic decisions, though the filing states no intent to influence control.

Key Dates

Recommendation

A seasoned investor would likely 'hold' based on this filing. While the disclosure of a significant stake by Mason Capital Management is a positive signal, a Schedule 13G filing primarily indicates passive investment intent. It does not provide new operational or financial performance data that would warrant a 'buy' or 'sell' recommendation, but rather confirms institutional interest, which supports maintaining current positions.

Keywords

Veradigm Inc., Mason Capital Management, beneficial ownership, Schedule 13G, common stock, healthcare technology, investment, stake, VDRM